Common Contracts
3 similar Commercialization Agreement contracts by Sera Prognostics, Inc.
SECOND AMENDMENT TO COMMERCIALIZATION AGREEMENTCommercialization Agreement • June 11th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
THIS Second Amendment to the January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively as “Parties.”
SECOND AMENDMENT TO COMMERCIALIZATION AGREEMENTCommercialization Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
THIS Second Amendment to the January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively as “Parties.”
SECOND AMENDMENT TO COMMERCIALIZATION AGREEMENTCommercialization Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories
THIS Second Amendment to the January 9, 2017 Commercialization Agreement (“Second Amendment”), effective as of the date this Second Amendment is signed by both parties (the “Effective Date”), is made by and between Sera Prognostics, Inc. (“Sera”) and Laboratory Corporation of America Holdings (“Labcorp”). Sera and Labcorp may be referred to herein each as a “Party” or collectively as “Parties.”
